Industry reports
Editor highlights

Publication dates

data types

Hospira Market and Forecasts, April 2014

You might be interested in: biosimilar, drug


» View Public Reports

1-10 of 52 reports for Hospira

Generic Drug in The United States and Australia : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 23 pages

... Refers to ims sales of equivalent products already being sold in the market. Lmv is not a forecast of hospira S expected sales revenue. . . Business model for biosimilars differs from trional ...

Drug and Medication : Innovation and Technology Trends

  • Industry report
  • November 2012
  • 12 pages

... Involving complex chemistry, multi-step manufacturing, dedicated infrastructure and a challenging patent environment circle5 apis sold under long-term supply agreement to hospira (for carbapenems, tazo ...

Drug and Medication Production and Trade Statistics in The United States and France

  • Industry report
  • December 2012
  • 25 pages

... E., Sandoz, hospira, app, and akorn strides), and two 189 generics studied by vesga et al (6): all of them met the quality specifications outlined in 190 the us pharmacopeia of not more than 9% of any one ...

The European Drug Sector Brief

  • Industry report
  • February 2012
  • 2 pages

... Include novartis division sandoz international, hospira inc. And teva pharmaceutical industries ltd. Several u.S.-Based brand-name drugmakers have also announced plans to develop biosimilars, including ...

Generic Drug Business Brief

  • Industry report
  • February 2013
  • 32 pages

... Mabs Celltrion, korea -hospira, egis, hikma, bb, etc Biocon & mylan, usa, mabs: xbiotech Teva & lonza, eu Limited range Biocon idec & samsung, japan Now merck Watson ...

Cardiovascular Drug Sector in The United States

  • Industry report
  • March 2012
  • 26 pages
  • by Research Paper

... Of pharmacy, 2008. 9. Trissel l. An update on usp chapter 797, the new national standard for sterile preparation. 07 April 2005. 10 Feb. 2009. - 10 ...

U.S. Generic Drug Industry Brief

  • Industry report
  • April 2012
  • 8 pages

... Paul greenland is the biosimilars director for the emea region at hospira and is based in leamington spa, uk. He has been in the pharmaceutical industry for more than 20 years, working in a variety ...

Biosimilar Market in China

  • Industry report
  • March 2014
  • 6 pages

... Including clinical development strategies for biosimilars in hospira inc and head of clinical operations in the eu. After graduating from london university in biochemistry, she worked in cancer research ...

Drug and Medication Industry Statistics in China

  • Industry report
  • May 2012
  • 31 pages

... Various hubei shine star flamma amino acids & derivatives jiangsu hansoh hospira gemcitabine hydrochloride ningbo smart novartis diclofenac sodium shenzhen hepalink app heparin zhejiang hisoar ...

Biosimilar Sector in Europe

  • Industry report
  • September 2013
  • 16 pages

... Teva hexal (novartis) teva hospira cephalon growth hormones somatropin genotropin omnitrope sandoz (novartis) source: biosimilar accessible market: size and biosimilar penetration; prepared ...

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.